Contact Us About Study Participation

Please call us at 773-989-8313 Ext. 2 to learn more. Otherwise, indicate your interest in a particular study by selecting one of the studies listed on this page and entering the study number in the appropriate form field.

Studies Form
Please copy and paste the study of interest here.
Please let us know any additional information here.
Sending

ALK3831-A303

A study to Evaluate Weight Gain of ALKS 3831 Compared to Olanzapine in Adults with Schizophrenia.

Official ClinicalTrials.gov Listing

LU 16159A

A study of Lu AF35700 in Patients With Treatment-Resistant Schizophrenia.

Official ClinicalTrials.gov Listing

ITI-007-401

A study to Assess the Efficacy and Safety of ITI-007 Monotherapy in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder.

Official ClinicalTrials.gov Listing

ITI-007-402

A study to Assess the Efficacy and Safety of ITI-007 Adjunctive to Lithium or Valproate in the Treatment of Patients With Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder.

Official ClinicalTrials.gov Listing

R092670SCH3013

A study in Subjects With Recent-Onset Schizophrenia or Schizophreniform Disorder to Compare Disease Progression and Disease Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics.

Official ClinicalTrials.gov Listing

HP-3070-US-07

A study to evaluate user comprehension of instructions for a transdermal patch to treat Schizophrenia.

Link Coming Soon

PAL-101

A bioequivalence study comparing paliperidone palmitate extended-release IM with Invega Sustenna in subjects with Schizophrenia and Schizoaffective Disorder.

Link Coming Soon